Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 473 - Heterocyclic compounds containing purine ring systems
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
08/2012
08/23/2012US20120214815 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
08/23/2012US20120213758 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
08/22/2012EP2488522A2 Novel method for preparing entecavir and intermediate used therein
08/22/2012EP2044070B1 Purine derivatives as a2a agonists
08/22/2012EP1778690B1 Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments
08/22/2012CN102643277A Refining method of ganciclovir
08/21/2012US8247549 Method for preparing 4-(6-amino-purin-9-YL)-2(S)-hydroxy-butyric acid methyl ester
08/16/2012WO2012107465A1 Heterocyclic compounds as pi3 kinase inhibitors
08/16/2012WO2012036573A3 Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction
08/16/2012US20120208831 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
08/16/2012US20120208829 2-phenoxy pyrimidinone analogues
08/16/2012US20120208806 Hsp90 Inhibitors
08/16/2012US20120207678 Labeled Adenosine for Use in Positron Emission Tomography
08/16/2012CA2825028A1 Heterocyclic compounds as pi3 kinase inhibitors
08/15/2012EP2487180A1 Novel artificial fluorescent bases
08/15/2012EP2486039A1 Purine derivatives useful as hsp90 inhibitors
08/15/2012EP2485731A1 Heterocyclic compounds useful as pdk1 inhibitors
08/15/2012EP2485589A1 Heteroaryl btk inhibitors
08/15/2012EP2358710B1 Akt and p70 s6 kinase inhibitors
08/15/2012EP1656370B1 Biaryl heterocyclic compounds and methods of making and using the same
08/15/2012CN102639534A Purine derivatives useful as hsp90 inhibitors
08/15/2012CN101827846B Valomaciclovir polymorphs
08/15/2012CN101489559B Purine and deazapurine derivatives as pharmaceutical compounds
08/09/2012WO2012105635A1 2-oxy-substituted 8-oxodihydropurine derivative
08/09/2012WO2012105629A1 Nitrogenated heterocyclic derivative, electron-transporting material for organic electroluminescent elements, and organic electroluminescent element using same
08/09/2012US20120202998 Novel method for preparing entecavir and intermediate used therein
08/09/2012US20120202785 Heterocyclic compounds and methods of use
08/09/2012US20120202287 Stem Cell Culture Methods
08/09/2012US20120201754 Phosphodiesterase 1-targeting tracers and methods
08/08/2012EP2483272A2 Pi3k (delta) selective inhibitors
08/08/2012EP2121693B1 8-oxoadenine derivatives as immuno-modulators
08/08/2012CN102627643A Refining method for ganciclovir
08/08/2012CN101490052B Therapeutic compounds and their use in cancer
08/08/2012CN101479268B 2-0'-methyladenosine derivatives and their use as agonists or antagonists of an adenosine receptor
08/07/2012US8236951 Thioxanthine derivatives as myeloperoxidase inhibitors
08/07/2012US8236810 Substituted 8-aminoalkylthioxanthines, and their use as inhibitors of dipeptidyl peptidase IV
08/07/2012US8236756 Prodrugs cleavable by CD26
08/02/2012WO2012101236A1 A photoluminescent molecular complex and method for determining of the concentration of said molecular complex
08/02/2012WO2012051296A3 Purine-based triazoles
08/02/2012WO2011113802A3 Imidazopyridine and purine compounds, compositions and methods of use
08/02/2012US20120196866 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
08/01/2012EP2482072A1 A photoluminescent probe
08/01/2012EP1848718B1 Inhibitors of e1 activating enzymes
08/01/2012CN102614743A Technological process for treatment of waste gas containing caffeine
07/2012
07/31/2012US8232275 2,2-bis-(hydroxymethyl)cyclopropylidenemethyl-purines and -pyrimidines as antiviral agents
07/26/2012US20120190850 Process for the preparation of valganciclovir hydrochloride
07/26/2012US20120190697 Hiv inhibiting bicyclic pyrimidine derivatives
07/26/2012US20120190679 Novel Protein Kinase B Inhibitors - 060
07/26/2012US20120190666 Heteroaryl Compounds as PIKK Inhibitors
07/26/2012US20120190639 Treatment or prophylaxis of proliferative conditions
07/25/2012CN102134241B Synthesis method of xanthinol nicotinate
07/24/2012US8227601 Diaryl-purines, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitor for treatment of HIV
07/19/2012US20120184569 A3 adenosine receptor agonists and antagonists
07/19/2012US20120184561 Phenylacetamides suitable as protein kinase inhibitors
07/19/2012US20120184516 sGC Stimulators
07/18/2012EP2476682A1 8-oxodihydropurine derivative
07/18/2012EP2475252A1 Selective antibacterials for clostridium difficile infections
07/18/2012EP1999132B1 Azolopyrimidines as inhibitors of cannabinoid 1 activity
07/18/2012CN1440408B Inhibitors of human phosphatidyl-inositol 3-kinase delta
07/18/2012CN102596956A Novel method for preparing entecavir and intermediate used therein
07/18/2012CN102584825A Method for synthesizing valaciclovir hydrochloride
07/18/2012CN101863888B Medicaments with HM74a receptor activity
07/18/2012CN101851238B Substituted 8-heteroaryl xanthines
07/18/2012CN101220070B Inosine and process for producing the same
07/17/2012US8222260 Substituted 6-anilinopurine derivatives as inhibitors of cytokinin oxidase/dehydrogenase and preparations containing these derivatives
07/17/2012US8222257 Phosphono-pent-2-en-1-yl nucleosides and analogs
07/17/2012CA2535313C Hiv replication inhibiting purine derivatives
07/17/2012CA2492659C 6-(3-pyridyl-methylamino)purine derivatives and their use as antiproliferative agents
07/12/2012US20120178743 Novel adenine compound and use thereof
07/12/2012US20120178716 Unsaturated Heterocyclic Derivatives
07/11/2012EP2474548A1 Preparation process of an antiviral drug and intermediates thereof
07/11/2012EP2473053A1 Substituted xanthine derivatives
07/11/2012EP2010535B1 Thioxanthine derivatives and their use as inhibitors of mpo
07/11/2012EP1866310B1 2,3-substituted fused pyrimidin-4(3h)-ones as vr1 antagonists
07/11/2012CN102558179A A purifying method of valacyclovir intermediate
07/10/2012US8217050 Adenine derivative as inhibitors of HSP90 for the treatment of cancer
07/05/2012WO2012092484A2 Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections
07/05/2012WO2012037498A3 Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo
07/05/2012US20120172591 Inhibitors of human phosphatidylinositol 3-kinase delta
07/05/2012US20120172347 8-oxodihydropurine derivative
07/05/2012US20120171730 Method and substances for preparation of n-substituted pyridinium compounds
07/04/2012EP2471533A1 Aryl carbonyl derivatives as therapeutic agents
07/04/2012EP2470535A2 Compositions, methods, and kits for determining an alkyl transferase
07/04/2012EP2470268A1 Purine-targeted diagnosis and therapy of wounds
07/04/2012EP1989206B1 Inhibitors of e1 activating enzyme
07/04/2012EP1550662B1 Adenine compound and use thereof
07/04/2012CN102548984A Inhibitors of PI3 kinase and / or MTOR
07/04/2012CN102532138A Synthesis method of anticoccidial drug adprin
07/04/2012CN102532137A 8-pyrazole substituted xanthine A2B adenosine receptor antagonist and synthesis method and application thereof
07/04/2012CN101880281B Thiophane nucleoside analogues and preparation method and application thereof
07/04/2012CN101531660B Industrialization production process of entecavir-monohydrate
06/2012
06/28/2012WO2012087881A1 N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
06/28/2012WO2012085209A1 Preparation process of an antiviral drug (entecavir) and intermediates thereof
06/28/2012US20120165525 Process for the preparation of linagliptin
06/28/2012US20120165350 Process for preparing an a2a-adenosine receptor agonist and its polymorphs
06/28/2012US20120164172 Cancer Therapy
06/28/2012CA2822070A1 N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
06/27/2012EP2468749A1 Process for the preparation of Linagliptin
06/27/2012CN102516245A Method for extracting caffeine from green tea
06/27/2012CN101715453B Heterocyclic compounds and their uses
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 120